ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing in patients with ulcerative colitis and Crohn's disease LOS ANGELES, CA / ...

The Government of Telangana today announced that it signed a non-binding Memorandum of Understanding (MoU) with Blaize Inc. earlier this week at the World Economic Forum in Davos, outlining the ...